Tandem Diabetes Care, Inc. (TNDM) — Analysis Summary
Tandem Diabetes Care, Inc. (TNDM) has a market cap of $1.49B with year-over-year revenue growth of +7.9%. Net margin stands at -20.2%. The stock trades at a P/E ratio of -23.5.
Key Takeaways
- Revenue changed +7.9% year-over-year
- Net margin of -20.2%
- P/E ratio of -23.5
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, TNDM posted revenue growth of +7.9% and trades at a P/E of -23.5.
Tandem Diabetes Care, Inc. (TNDM)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -5.2x — earnings do not cover interest payments
D/E at 4.6x — high financial leverage
The latest filing shows negative free cash flow.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
2,500
Headquarters
San Diego, CA
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.